Analyst Ratings For Correvio Pharma Corp (NASDAQ:CORV)
Today, HC Wainwright set its price target on Correvio Pharma Corp (NASDAQ:CORV) to $11.00 per share.
There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Correvio Pharma Corp (NASDAQ:CORV) is Buy with a consensus target price of $11.00 per share, a potential 194.12% upside.
Some recent analyst ratings include
- 10/12/2018-Correvio Pharma Corp (NASDAQ:CORV) gets upgraded to Buy by Mackie
Recent Trading Activity for Correvio Pharma Corp (NASDAQ:CORV)
Shares of Correvio Pharma Corp closed the previous trading session at 3.74 −0.19 4.83% with 3.71 shares trading hands.